EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial Transplantation Ameliorates Pulmonary Fibrosis by Suppressing Myofibroblast Activation

Seo-Eun Lee, Shin-Hye Yu iD, In-Hyeon Kim iD, Young Cheol Kang, Yujin Kim, Jeong Seon Yeo, Jun Hyeok Lim iD, Iksun Kwon, Je-Hein Kim, Se-Woong Park, Mi-Yoon Chang, Kyuboem Han iD und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Seo-Eun Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Paean Biotechnology, Inc., 5 Samil-daero 8-gil, Jung-gu, Seoul 04552, Republic of Korea. Hauptthemen laut MEDLINE: Mitochondria, Myofibroblasts, Idiopathic Pulmonary Fibrosis, Disease Models, Animal. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, The Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a pulmonary disease characterized by excessive extracellular matrix protein deposition in the lung interstitium, subsequently causing respiratory failure. IPF still has a high medical unmet requirement due to the lack of effective treatments to inhibit disease progression. The etiology of IPF remains unclear, but mitochondrial dysfunction is considered to be associated with IPF development. Therefore, targeting mitochondrial abnormalities would be a promising strategy for treating IPF. Recently, exogenous mitochondrial transplantation has been beneficial for treating mitochondrial dysfunction. The current study aimed to examine the therapeutic effect of mitochondrial transplantation on IPF in vitro and in vivo. Mitochondria were isolated from human umbilical cord mesenchymal stem cells, referred to as PN-101. Human lung fibroblasts and human bronchial epithelial cells were exposed to transforming growth factor-β, followed by PN-101 treatment to determine the in vitro efficacy of mitochondrial transplantation. An IPF mouse model established by a single intratracheal instillation of bleomycin was utilized to determine the in vivo efficacy of the intravenously treated mitochondria. PN-101 attenuated mitochondrial damage, inhibited EMC production, and suppressed epithelial-to-mesenchymal transition in vitro. Additionally, intravenous PN-101 administration alleviated bleomycin-induced fibrotic processes in the IPF mouse model with a therapeutic context. Our data indicate that PN-101 is a novel and potential therapeutic agent for IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaMyofibroblastsIdiopathic Pulmonary FibrosisDisease Models, AnimalBleomycinAnimalsHumansMiceEpithelial-Mesenchymal TransitionMesenchymal Stem CellsMice, Inbred C57BLMale

Stichwörter der Autor:innen

anti-inflammationantiapoptosisidiopathic pulmonary fibrosis (IPF)mitochondriastem celltransplantation

Substanzen

Bleomycin

Autor:innen und Institutionen

  • Paean Biotechnology, Inc., 5 Samil-daero 8-gil, Jung-gu, Seoul 04552, Republic of Korea.
  • Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul 04763, Republic of Korea.
  • Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, Jeongeup 56212, Republic of Korea.
  • College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Department of Premedicine, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea.

ORCID-Profile: Shin-Hye Yu, In-Hyeon Kim, Jun Hyeok Lim, Kyuboem Han, Sung-Hwan Kim

Förderung

  • National Research Foundation of Korea
  • The Ministry of Science and ICT

Zitieren

APA

Lee, S. E., Yu, S. H., Kim, I. H., Kang, Y. C., Kim, Y., Yeo, J. S., Lim, J. H., Kwon, I., Kim, J. H., Park, S. W., Chang, M. Y., Han, K., Kim, S. H., & Kim, C. H. (2024). Mitochondrial Transplantation Ameliorates Pulmonary Fibrosis by Suppressing Myofibroblast Activation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312783

Vancouver

Lee SE, Yu SH, Kim IH, Kang YC, Kim Y, Yeo JS, et al. Mitochondrial Transplantation Ameliorates Pulmonary Fibrosis by Suppressing Myofibroblast Activation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312783

BibTeX
@article{Lee2024,
  author = {Lee, Seo-Eun and Yu, Shin-Hye and Kim, In-Hyeon and Kang, Young Cheol and Kim, Yujin and Yeo, Jeong Seon and Lim, Jun Hyeok and Kwon, Iksun and Kim, Je-Hein and Park, Se-Woong and Chang, Mi-Yoon and Han, Kyuboem and Kim, Sung-Hwan and Kim, Chun-Hyung},
  title = {Mitochondrial Transplantation Ameliorates Pulmonary Fibrosis by Suppressing Myofibroblast Activation},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312783}
}
Kostenlos starten →